Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Biliary Tract Neoplasms (Phase 2/Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Colorectal Neoplasms (Phase 2)
Exocrine Pancreatic Insufficiency (Phase 1)
Hamartoma (Phase 2)
Healthy Volunteers (Phase 1)
Intestinal Neoplasms (Phase 2)
Kidney Failure, Chronic (Phase 1)
Liver Diseases (Phase 1)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 1/Phase 2)
Nasopharyngeal Carcinoma (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neuroendocrine Tumors (Phase 3)
Osteosarcoma (Phase 1/Phase 2)
Rhabdomyosarcoma (Phase 1/Phase 2)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 1/Phase 2)
Small Cell Lung Carcinoma (Phase 1/Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 1/Phase 2)
Thyroid Carcinoma, Anaplastic (Phase 1/Phase 2)
Thyroid Neoplasms (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue